Tandem Diabetes Care (TNDM) Share-based Compensation (2013 - 2026)

Tandem Diabetes Care's Share-based Compensation history runs 14 years deep, the most recent figure standing at $15.7 million for Q1 2026.

• Quarterly Share-based Compensation fell 38.56% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (down 86.88% YoY) and the FY2025 annual result came in at $26.2 million, down 74.19% from the prior year.
• Share-based Compensation was $15.7 million for Q1 2026 at Tandem Diabetes Care, up from -$25.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $92.4 million in Q2 2022 and bottomed at -$50.0 million in Q3 2022.
• A 5-year average of $19.8 million and a median of $22.3 million in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation sank 289.8% — and 2025, when it surged 1011.12%.
• Tandem Diabetes Care's Share-based Compensation stood at $24.4 million in 2022, then surged by 260.36% to $88.1 million in 2023, then climbed by 4.85% to $92.4 million in 2024, then slumped by 127.03% to -$25.0 million in 2025, then jumped by 162.74% to $15.7 million in 2026.
• Business Quant data shows TNDM's Share-based Compensation at $15.7 million in Q1 2026, -$25.0 million in Q3 2025, and $25.6 million in Q2 2025.